Innovative Breakthrough: BioRestorative Therapies Secures Key Patent for Obesity Treatment Program
BioRestorative Therapies, Inc., a pioneering clinical-stage company specializing in stem cell-based therapies, has achieved a significant milestone in its quest to combat obesity and metabolic disorders. The United States Patent and Trademark Office has issued a notice of allowance for a patent application related to the company’s ThermoStem® program. This development, announced on December 12, […]
RoslinCT and the Revolutionary CRISPR-Based Gene Therapy CASGEVY™
RoslinCT, a renowned cell and gene therapy Contract Development and Manufacturing Organisation (CDMO), has achieved a groundbreaking milestone in the field of medical science. Building on its legacy since the cloning of Dolly the Sheep at the Roslin Institute in 1997, RoslinCT has now been entrusted with the manufacturing of the first-ever U.S. Food and […]
Gallant Therapeutics Launches JEDI Study for Feline Chronic Gingivostomatitis
Gallant Therapeutics, a pioneering biotechnology company in animal health, has announced the initiation of the JEDI study, a pivotal trial to assess the safety and effectiveness of a novel allogeneic stem cell therapy for cats suffering from refractory feline chronic gingivostomatitis (FCGS). This groundbreaking study represents a potential first-in-class therapy for a severe disease that […]
Revolutionizing Aging: Venvalo Group Unveils Immorta Bio, Inc for Personalized Cell Therapy in Age-Related Disease Treatment
Venvalo Group, a venture value optimization firm, has recently announced the formation of Immorta Bio, Inc. This new regenerative medicine company is set to revolutionize the treatment of aging and diseases associated with aging by providing patient-specific therapeutic solutions. Pioneering Personalized Regenerative Medicine Immorta Bio, Inc. is spearheading the development of personalized stem cell technologies, […]
Revolutionizing Women’s Health: Harvard Apparatus’s Breakthrough in Uterine Regeneration and Fertility Restoration
Harvard Apparatus Regenerative Technology, a clinical-stage biotechnology company, has announced a new collaboration with Dr. Hugh Taylor, chair of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine. This partnership, formalized through a Sponsored Research Agreement, aims to tackle a significant women’s health issue: intrauterine adhesions (IUAs). These adhesions, leading to infertility and menstrual […]
RoslinCT Unveils CRISPR: A Medical Revolution Begins
RoslinCT, a renowned cell and gene therapy Contract Development and Manufacturing Organisation (CDMO), has announced a significant advancement in the field of medical science. They will be manufacturing the world’s first CRISPR-based therapy, exa-cel, for Vertex Pharmaceuticals Inc. This development follows an extensive collaboration between the two entities. Key Highlights: About RoslinCT: RoslinCT has a […]
Aspen Neuroscience Cofounder Dr. Andrés Bratt-Leal Receives 2023 Biocom California Life Science Catalyst Award
Dr. Andrés Bratt-Leal, co-founder and Senior Vice President of Research and Development at Aspen Neuroscience, has been honored with the prestigious 2023 Biocom California Life Science Catalyst Award. This accolade, presented by Biocom California, recognizes the most inspiring and driven young minds in the California life sciences industry who are making significant contributions to human […]
UP421: Revolutionizing Diabetes Treatment Without Immunosuppression
Uppsala University Hospital and Sana Biotechnology recently announced a groundbreaking development in diabetes treatment. They have received authorization from the Swedish Medical Products Agency for a first-in-human clinical trial of UP421, a novel islet cell therapy for type 1 diabetes. This treatment, developed using Sana’s innovative hypoimmune (HIP) technology, aims to transplant functional islet cells […]
Revolutionizing Stem Cell Research: ACROBiosystems’ DLL4
ACROBiosystems, a pivotal player in the pharmaceutical industry, recently announced the launch of its GMP grade DLL4, a significant advancement in the field of stem cell research and biologics manufacturing. DLL4, or Delta-like Ligand 4, is a recombinant, soluble protein now available in a GMP (Good Manufacturing Practice) compliant form. This launch marks a considerable […]
Revolutionizing Treatment: Century Therapeutics and FUJIFILM’s Groundbreaking Alliance to Combat Autoimmune Diseases with Stem Cell Therapies
In a significant development for the treatment of autoimmune and inflammatory diseases, Century Therapeutics, Inc., a trailblazing biotechnology company, and FUJIFILM Cellular Dynamics, Inc., a prominent developer and manufacturer of human induced pluripotent stem cells (iPSCs) and iPSC-derived cells, have announced a worldwide license agreement. This collaboration is set to advance the development and commercialization […]